Abstract Background Australians with chronic hepatitis C (HCV) can access affordable Direct Acting Antiviral (DAA) treatments with high cure rates (>90%), via General Practitioners (GPs). Benefits from this treatment will be maximised if people with HCV readily disclose and engage with private GPs regarding HCV-related issues. Investigating the perceptions and experiences of people affected by HCV with GPs can allow for this pathway to care for HCV to be improved. Methods In 2013–2014, 22 purposively sampled participants from South Australia (SA) were interviewed. They a) had contracted or were at risk of hepatitis C (n = 10), b) were key workers who had clients affected by HCV (n = 6), and c) met both a) and b) criteria (n = 6). The semi-s...
The ease of direct-acting antiviral (DAA) medications for hepatitis C virus (HCV) has provided an op...
Background: Australia is committed to eliminating the hepatitis C virus (HCV) by 2030. Despite regul...
Objective: To estimate the hepatitis C patient caseload of general practitioners and explore their p...
This article is distributed under the terms of the Creative Commons Attribution 4.0 International Li...
The recent implementation of a scheme to provide universal access to direct-acting antiviral (DAA) m...
The availability of new antiviral agents opens the way for increasing GP involvement in the manageme...
To increase access to treatment, the Australian government enabled general practitioners (GPs) to pr...
There is a growing debate about the prescription of hepatitis C virus (HCV) antiviral therapies with...
The ease of direct‐acting antiviral (DAA) medications for hepatitis C virus (HCV) has provided an op...
Background: Although the availability of fully funded direct-acting antivirals (DAAs) and the eligib...
There is an increasing burden on the community resulting from chronic hepatitis B infection. General...
Background: In Australia, only 22% of people with chronic hepatitis B (CHB) are clinically managed; ...
Abstract Objective: General Practitioners (GPs) are essential to reducing the impact of chronic hepa...
The ease of direct-acting antiviral (DAA) medications for hepatitis C virus (HCV) has provided an op...
An estimated 170 million people worldwide have hepatitis C, which is a significant cause of morbidit...
The ease of direct-acting antiviral (DAA) medications for hepatitis C virus (HCV) has provided an op...
Background: Australia is committed to eliminating the hepatitis C virus (HCV) by 2030. Despite regul...
Objective: To estimate the hepatitis C patient caseload of general practitioners and explore their p...
This article is distributed under the terms of the Creative Commons Attribution 4.0 International Li...
The recent implementation of a scheme to provide universal access to direct-acting antiviral (DAA) m...
The availability of new antiviral agents opens the way for increasing GP involvement in the manageme...
To increase access to treatment, the Australian government enabled general practitioners (GPs) to pr...
There is a growing debate about the prescription of hepatitis C virus (HCV) antiviral therapies with...
The ease of direct‐acting antiviral (DAA) medications for hepatitis C virus (HCV) has provided an op...
Background: Although the availability of fully funded direct-acting antivirals (DAAs) and the eligib...
There is an increasing burden on the community resulting from chronic hepatitis B infection. General...
Background: In Australia, only 22% of people with chronic hepatitis B (CHB) are clinically managed; ...
Abstract Objective: General Practitioners (GPs) are essential to reducing the impact of chronic hepa...
The ease of direct-acting antiviral (DAA) medications for hepatitis C virus (HCV) has provided an op...
An estimated 170 million people worldwide have hepatitis C, which is a significant cause of morbidit...
The ease of direct-acting antiviral (DAA) medications for hepatitis C virus (HCV) has provided an op...
Background: Australia is committed to eliminating the hepatitis C virus (HCV) by 2030. Despite regul...
Objective: To estimate the hepatitis C patient caseload of general practitioners and explore their p...